Orchid Pharma Limited – NSE:ORCHPHARMA.NS
Orchid Pharma Limited stock price today
Orchid Pharma Limited stock price monthly change
Orchid Pharma Limited stock price quarterly change
Orchid Pharma Limited stock price yearly change
Orchid Pharma Limited key metrics
Market Cap | 87.57B |
Enterprise value | 18.92B |
P/E | -89.75 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 2.50 |
Price/Book | 2.55 |
PEG ratio | -0.91 |
EPS | 18.36 |
Revenue | 8.19B |
EBITDA | 1.27B |
Income | 921.66M |
Revenue Q/Q | 3.43% |
Revenue Y/Y | 23.04% |
Profit margin | -3.06% |
Oper. margin | 5.23% |
Gross margin | 40.01% |
EBIT margin | 5.23% |
EBITDA margin | 15.58% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrchid Pharma Limited stock price history
Orchid Pharma Limited stock forecast
Orchid Pharma Limited financial statements
| Jun 2023 | 1.82B | 94.04M | 5.14% |
|---|---|---|---|
| Sep 2023 | 1.98B | 198.03M | 9.96% |
| Dec 2023 | 2.20B | 294.31M | 13.34% |
| Mar 2024 | 2.17B | 335.26M | 15.44% |
| 2026 | 14.84B | 2.17B | 14.63% |
|---|---|---|---|
| 2027 | 22.52B | 4.67B | 20.76% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 14920843000 | 3.84B | 25.75% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 15538739000 | 3.84B | 24.74% |
| Mar 2023 | 144.24M | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 154.15M | 0 | 0 |
| Sep 2023 | 156.81M | 0 | 0 |
| Dec 2023 | 185.37M | 0 | 0 |
Orchid Pharma Limited alternative data
| Aug 2023 | 946 |
|---|---|
| Sep 2023 | 838 |
| Oct 2023 | 838 |
| Nov 2023 | 838 |
| Dec 2023 | 838 |
| Jan 2024 | 838 |
| Feb 2024 | 838 |
| Mar 2024 | 838 |
| Apr 2024 | 838 |
| May 2024 | 838 |
| Jun 2024 | 838 |
| Jul 2024 | 838 |
Orchid Pharma Limited other data
| Insider | Compensation |
|---|---|
Mr. Mridul Dhanuka (1980) Whole Time Director | $5,070,000 |
Mr. Manish Dhanuka (1967) MD & Director | $5,070,000 |
-
What's the price of Orchid Pharma Limited stock today?
One share of Orchid Pharma Limited stock can currently be purchased for approximately $399.75.
-
When is Orchid Pharma Limited's next earnings date?
Unfortunately, Orchid Pharma Limited's (ORCHPHARMA.NS) next earnings date is currently unknown.
-
Does Orchid Pharma Limited pay dividends?
No, Orchid Pharma Limited does not pay dividends.
-
How much money does Orchid Pharma Limited make?
Orchid Pharma Limited has a market capitalization of 87.57B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 46.43% to 8.19B US dollars.
-
What is Orchid Pharma Limited's stock symbol?
Orchid Pharma Limited is traded on the NSE under the ticker symbol "ORCHPHARMA.NS".
-
What is Orchid Pharma Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Orchid Pharma Limited?
Shares of Orchid Pharma Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Orchid Pharma Limited's key executives?
Orchid Pharma Limited's management team includes the following people:
- Mr. Mridul Dhanuka Whole Time Director(age: 45, pay: $5,070,000)
- Mr. Manish Dhanuka MD & Director(age: 58, pay: $5,070,000)
-
How many employees does Orchid Pharma Limited have?
As Jul 2024, Orchid Pharma Limited employs 838 workers.
-
When Orchid Pharma Limited went public?
Orchid Pharma Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is Orchid Pharma Limited's official website?
The official website for Orchid Pharma Limited is orchidpharma.com.
-
How can i contact Orchid Pharma Limited?
Orchid Pharma Limited can be reached via phone at +91 44 2821 1000.
Orchid Pharma Limited company profile:
Orchid Pharma Limited
orchidpharma.comNSE
871
Drug Manufacturers - Specialty & Generic
Healthcare
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.
Chennai, 600034
:
ISIN: INE191A01027
:
